$AXON

Kalinowski Caitlin Elizabeth sold $77K of AXON

Kalinowski Caitlin Elizabeth sold 160 shares of AXON ENTERPRISE, INC. (AXON) at $482.93 on 2026-06-01.

Original reporting
SEC EDGAR · Kalinowski Caitlin Elizabeth
Published Jun 2, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

This adds incremental sentiment information for AXON but does not introduce new company fundamentals (earnings, guidance, contracts, litigation, or product/drug trial results).

02

Market read

Use as a small sentiment/positioning input; treat as low-impact unless corroborated by broader insider selling trends or other catalysts.

03

What to watch

No 10b5-1 plan is stated, but Form 4s can still reflect pre-planned schedules or personal needs; traders should check for prior insider transactions and overall insider net activity.

Relevance 4/10Novelty 6/10Timing: After-hours/next-session read-through from a newly filed Form 4 (filed 2026-06-02).

Background

The article is an SEC Form 4 insider transaction disclosure for Axon Enterprise (AXON), reporting an open-market sale by a director.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon Enterprise director Caitlin Kalinowski sold 160 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-01.

Expected impact

Low near-term impact; any effect is likely limited to short-lived sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing provides a discrete sale size and price but no accompanying company-specific operational or financial change.

Market effects

Minimal; this is company-specific insider activity with no sector-wide policy or regulatory change mentioned.

None indicated.

None indicated.

Counterpoint

Director selling can be routine liquidity management; without evidence of a pattern or linkage to performance, the market may discount it quickly.

Key entities

  • AXON ENTERPRISE, INC.

    Public company whose director insider sale is disclosed on SEC Form 4.

  • Caitlin Elizabeth Kalinowski

    Director who sold 160 shares at $482.93/share on 2026-06-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXONHighAI 9/10

Axon’s (AXON) Dilution Fears Look Overstated

Axon Enterprise (AXON) stock fell after announcing a $1B convertible-note offering, but analysts argue dilution fears are overstated. The notes carry 0% interest, convert at $652.06, and are hedged to $1,049.94. Q2 revenue rose 35% to $904M, marking 10 straight quarters of over 30% growth. Management raised full-year revenue growth outlook to 32-34%. AXON has a Strong Buy consensus rating, with an average price target of $719.55.

$AXONHighAI 8/10

Why Did Axon Stock Fall Ten Percent On A Convertible That Pays No Interest?

Axon Enterprise (AXON) shares dropped 9.8% after announcing a $1.0 billion convertible note offering with a 0% coupon. The market interpreted this as a sign of cash flow challenges despite strong revenue growth (34.6% YoY). The company cited inventory investments and rising component costs. AXON's stock is now 43% below its 52-week high, trading at 11x trailing revenue with shrinking margins.

$AXONHighAI 9/10

Axon Q2FY26 Results: Revenue rises 35% to $904 million, guidance raised

Axon Enterprise reported Q2FY26 revenue of $904M, up 35% YoY, and raised full-year guidance to 32-34% growth. Software & services revenue rose 36% to $398M, while connected devices revenue grew 35% to $507M. Platform solutions revenue surged 123% to $150M. The company plans a $1B convertible note offering due 2031, with net proceeds for general corporate purposes and capped call transactions. Shares were up 0.50% in premarket trading.

$AXONHighAI 8/10

Full Transcript: Axon Enterprise Q2 2026 Earnings Call - (AXON)

Axon Enterprise (AXON) reported a record Q2 2026 with 39% growth, driven by demand for Dedrone, Taser 10, and Axon Body 4. The company raised its full-year revenue guidance to 32-34% growth, citing strong bookings and market expansion. Management highlighted investments in AI and public safety technologies, emphasizing trust and data privacy.

$AXONMedAI 8/10

Axon Rebounded 6% Wednesday. Here’s What Could Drive the Stock Through 2026

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.